552 related articles for article (PubMed ID: 23688711)
1. Enhanced depth imaging optical coherence tomography of the choroid in central retinal vein occlusion.
Tsuiki E; Suzuma K; Ueki R; Maekawa Y; Kitaoka T
Am J Ophthalmol; 2013 Sep; 156(3):543-547.e1. PubMed ID: 23688711
[TBL] [Abstract][Full Text] [Related]
2. Choroidal volume in branch retinal vein occlusion before and after intravitreal anti-VEGF injection.
Chung YK; Shin JA; Park YH
Retina; 2015 Jun; 35(6):1234-9. PubMed ID: 25574783
[TBL] [Abstract][Full Text] [Related]
3. Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion.
Rayess N; Rahimy E; Ying GS; Pefkianaki M; Franklin J; Regillo CD; Ho AC; Hsu J
Am J Ophthalmol; 2016 Nov; 171():47-52. PubMed ID: 27567889
[TBL] [Abstract][Full Text] [Related]
4. Subfoveal choroidal thickness in idiopathic choroidal neovascularization and treatment outcomes after intravitreal bevacizumab therapy.
Kim H; Lee K; Lee CS; Byeon SH; Lee SC
Retina; 2015 Mar; 35(3):481-6. PubMed ID: 25313710
[TBL] [Abstract][Full Text] [Related]
5. Subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
Maruko I; Iida T; Oyamada H; Sugano Y; Saito M; Sekiryu T
Retina; 2015 Apr; 35(4):648-54. PubMed ID: 25627088
[TBL] [Abstract][Full Text] [Related]
6. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.
Kang HM; Kwon HJ; Yi JH; Lee CS; Lee SC
Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050
[TBL] [Abstract][Full Text] [Related]
7. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
[TBL] [Abstract][Full Text] [Related]
8. Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
Okamoto M; Matsuura T; Ogata N
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):25-32. PubMed ID: 25559505
[TBL] [Abstract][Full Text] [Related]
9. Regional Choroidal Thickness Changes in Branch Retinal Vein Occlusion with Macular Edema.
Kim KH; Lee DH; Lee JJ; Park SW; Byon IS; Lee JE
Ophthalmologica; 2015; 234(2):109-18. PubMed ID: 26305536
[TBL] [Abstract][Full Text] [Related]
10. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema.
Rayess N; Rahimy E; Ying GS; Bagheri N; Ho AC; Regillo CD; Vander JF; Hsu J
Am J Ophthalmol; 2015 Jan; 159(1):85-91.e1-3. PubMed ID: 25261844
[TBL] [Abstract][Full Text] [Related]
11. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
12. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
[TBL] [Abstract][Full Text] [Related]
13. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
[TBL] [Abstract][Full Text] [Related]
14. Management of Choroidal Neovascular Membranes Associated with Choroidal Nevi.
Munie MT; Demirci H
Ophthalmol Retina; 2018 Jan; 2(1):53-58. PubMed ID: 31047303
[TBL] [Abstract][Full Text] [Related]
15. Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration.
Kim JH; Kim JR; Kang SW; Kim SJ; Ha HS
Am J Ophthalmol; 2013 Apr; 155(4):743-9, 749.e1-2. PubMed ID: 23317655
[TBL] [Abstract][Full Text] [Related]
16. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
[TBL] [Abstract][Full Text] [Related]
17. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization.
Ahn SJ; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418
[TBL] [Abstract][Full Text] [Related]
18. Subfoveal choroidal thickness change after intravitreal ranibizumab for idiopathic choroidal neovascularization.
Cao XS; Peng XY; You QS; Zhang YP; Jonas JB
Retina; 2014 Aug; 34(8):1554-9. PubMed ID: 24667570
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
20. Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy.
Maruko I; Iida T; Oyamada H; Sugano Y; Ojima A; Sekiryu T
Am J Ophthalmol; 2013 Sep; 156(3):548-556. PubMed ID: 23810474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
